(Q53961377)

23 May 2018

title

Evaluation of carprofen in calves using a tissue cage model of inflammation. (English)

1 reference

23 May 2018

0 references

Lees P

1

1 reference

23 May 2018

Delatour P

2

1 reference

23 May 2018

Foster AP

3

1 reference

23 May 2018

Foot R

4

1 reference

23 May 2018

Baggot D

5

1 reference

23 May 2018

publication date

1 March 1996

1 reference

23 May 2018

British Veterinary Journal

published in

1 reference

23 May 2018

volume

152

1 reference

23 May 2018

issue

2

1 reference

23 May 2018

page(s)

199-211

1 reference

23 May 2018

The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980074-1

Pharmacodynamics and chiral pharmacokinetics of carprofen in calves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980074-1

Stereoisomeric relationships among anti-inflammatory activity, inhibition of platelet aggregation, and inhibition of prostaglandin synthetase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980074-1

Arachidonic acid metabolites in carrageenin-induced equine inflammatory exudate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980074-1

Tissue-cage model for the collection of inflammatory exudate in ponies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980074-1

Measurement of flunixin in equine inflammatory exudate and plasma by high performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980074-1

Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980074-1

Pharmacokinetics and pharmacodynamics of ketoprofen in calves applying PK/PD modelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980074-1

Flunixin inhibits prostaglandin E2 production in equine inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980074-1

Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980074-1

Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980074-1

Pharmacodynamics and pharmacokinetics of carprofen in the horse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980074-1

Phmacodynamics and pharmacokinetics of carprofen, a non-steroidal anti-inflammatory drug, in healthy cows and cows with Escherichia coli endotoxin-induced mastitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980074-1

Stereospecific pharmacodynamics and pharmacokinetics of carprofen in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980074-1

Equipotent inhibition by R(-)-, S(+)- and racemic ibuprofen of human polymorphonuclear cell function in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0007-1935%2896%2980074-1

10.1016/S0007-1935(96)80074-1

7 January 2021

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018